UPDATE: 3 March 2024, 8:14 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Dementia is most widely associated with its cognitive symptoms, like memory loss. But it often brings a host of behavioral symptoms, too, like agitation…
Alzheimer’s disease affects one in every three people over the age of 85, and the scale of the epidemic is only worsening. While there…
In January of 2023, the Food and Drug Administration approved the second anti-amyloid therapy for Alzheimer’s disease, Leqembi (generic name lecanemab). A new Alzheimer’s…
Over 55 million people worldwide have dementia. This mind-robbing condition has a huge impact on society and the economy, so scientists are working hard…
I’m writing from Amsterdam, where this past week, the Being Patient editorial team has been reporting on the biggest news from the Alzheimer’s Association…
This article was made possible through sponsorship by Lexeo Therapeutics. Being Patient’s editorial team produced the interview and article with no review/approval process by the…
American pharmaceutical company Eli Lilly announced in May 2023 that it had seen encouraging clinical trial results of its new Alzheimer’s medication. According to…
This article was made possible through sponsorship by Lexeo Therapeutics. Being Patient’s editorial team produced the interview and article, with no review/approval process by…
The brain’s neurons communicate with each other through chemical and electrical signals. But as Alzheimer’s disease develops, protein plaques and deposits buildup and kill…
Alzheimer’s is so far incurable, but there are medications out there that can help manage symptoms and improve quality of life for patients and…
Since the United States imposed an embargo on Cuba in 1961, the island nation has built a robust healthcare system on their own, with…
As many as half of people who develop Alzheimer’s dementia experience the symptom of agitation, which can lead to behaviors like pacing, restlessness, and…
After almost two decades of stagnation, two new drugs for Alzheimer’s have hit the market in the last three years. The approval of Biogen…
Despite decades of study, the underlying cause of Alzheimer’s continues to evade scientists. Because it’s such a mystery, there are only six drugs approved for…